INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | +20.6% | 3,263 | 0.0% | 0.00% | – |
| Q2 2023 | $68 | -84.6% | 3,263 | -87.4% | 0.00% | -100.0% |
| Q1 2023 | $442 | +927.9% | 25,958 | +1102.9% | 0.00% | – |
| Q4 2022 | $43 | -100.0% | 2,158 | -80.1% | 0.00% | – |
| Q3 2022 | $233,000 | -8.6% | 10,848 | -16.3% | 0.00% | – |
| Q2 2022 | $255,000 | -52.3% | 12,968 | -43.1% | 0.00% | -100.0% |
| Q1 2022 | $535,000 | -34.9% | 22,785 | -24.5% | 0.00% | 0.0% |
| Q4 2021 | $822,000 | -39.5% | 30,189 | -38.8% | 0.00% | -50.0% |
| Q3 2021 | $1,358,000 | +1686.8% | 49,345 | +2036.1% | 0.00% | – |
| Q4 2020 | $76,000 | +10.1% | 2,310 | +6.4% | 0.00% | – |
| Q3 2020 | $69,000 | +40.8% | 2,171 | -30.4% | 0.00% | – |
| Q1 2020 | $49,000 | +1125.0% | 3,119 | +1034.2% | 0.00% | – |
| Q3 2013 | $4,000 | – | 275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |